Article
Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets.
BMC cancer - 10 Aug 2022
Alnoumas Layla, van den Driest Lisa, Apczynski Zoe, Lannigan Alison, Johnson Caroline H, Rattray Nicholas J W, Rattray Zahra
Abstract excerpt
Breast cancer, comprising of several sub-phenotypes, is a leading cause of female cancer-related mortality in the UK and accounts for 15% of all cancer cases. Chemoresistant sub phenotypes of breast cancer remain a particular challenge. However, the rapidly-growing availability of clinical datasets, presents the scope to underpin a data-driven precision medicine-based approach exploring new targets for diagnostic...
Topics
Join the communities discussing this publication.
